Publikationen in Zusammenarbeit mit Forschern von St. Michael's Hospital (18)

2024

  1. Impact of mediterranean diet promotion on environmental sustainability: a longitudinal analysis

    Public Health, Vol. 230, pp. 12-20

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Association of adiposity and its changes over time with COVID-19 risk in older adults with overweight/obesity and metabolic syndrome: a longitudinal evaluation in the PREDIMED-Plus cohort

    BMC Medicine, Vol. 21, Núm. 1

  3. Higher versus lower nut consumption and changes in cognitive performance over two years in a population at risk of cognitive decline: a cohort study

    American Journal of Clinical Nutrition, Vol. 118, Núm. 2, pp. 360-368

  4. How Did the COVID-19 Lockdown Pandemic Affect the Depression Symptomatology in Mediterranean Older Adults with Metabolic Syndrome?

    Depression and Anxiety, Vol. 2023

  5. Impact of COVID-19 pandemic on the PREDIMED-Plus randomized clinical trial: Effects on the interventions, participants follow-up, and adiposity

    Frontiers in Nutrition, Vol. 9

  6. Intensive Weight-Loss Lifestyle Intervention Using Mediterranean Diet and COVID-19 Risk in Older Adults: Secondary Analysis of PREDIMED-Plus Trial

    Journal of Nutrition, Health and Aging, Vol. 27, Núm. 12, pp. 1162-1167

  7. Water intake, hydration status and 2-year changes in cognitive performance: a prospective cohort study

    BMC medicine, Vol. 21, Núm. 1, pp. 82

2022

  1. Dairy Product Consumption and Changes in Cognitive Performance: Two-Year Analysis of the PREDIMED-Plus Cohort

    Molecular Nutrition and Food Research, Vol. 66, Núm. 14

  2. Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 68

  3. One-year changes in fruit and vegetable variety intake and cardiometabolic risk factors changes in a middle-aged Mediterranean population at high cardiovascular risk

    European Journal of Clinical Nutrition, Vol. 76, Núm. 10, pp. 1393-1402

2021

  1. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433

  2. Longitudinal changes in adherence to the portfolio and DASH dietary patterns and cardiometabolic risk factors in the PREDIMED-Plus study

    Clinical Nutrition, Vol. 40, Núm. 5, pp. 2825-2836

  3. Mediterranean, DASH, and MIND Dietary Patterns and Cognitive Function: The 2-Year Longitudinal Changes in an Older Spanish Cohort

    Frontiers in Aging Neuroscience, Vol. 13

2019

  1. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628

2018

  1. Alirocumab and cardiovascular outcomes after acute coronary syndrome

    New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107

2007

  1. Do α-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: A cohort study

    Neurology, Vol. 68, Núm. 23, pp. 2012-2018

  2. PLUTO trial protocol: Percutaneous shunting for lower urinary tract obstruction randomised controlled trial

    BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 114, Núm. 7